Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -166,550 | -200,973 | -56,289 | N/A | N/A |
| Depreciation Amortization | 44,257 | 37,964 | 25,963 | N/A | N/A |
| Accounts receivable | -283,160 | 3,292 | -22,123 | N/A | N/A |
| Accounts payable and accrued liabilities | 233,695 | -90,246 | -24,773 | N/A | N/A |
| Other Working Capital | -106,345 | -93,448 | -48,375 | N/A | N/A |
| Other Operating Activity | 262,711 | 121,051 | 56,885 | 0 | 0 |
| Operating Cash Flow | $-15,391 | $-222,361 | $-68,711 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -74,012 | -43,200 | -35,304 | N/A | N/A |
| Net Acquisitions | -69,273 | -6,783 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -22,176 | -36,387 | -43,999 | N/A | N/A |
| Other Investing Activity | -22,176 | -36,387 | -43,998 | 0 | 0 |
| Investing Cash Flow | $-165,460 | $-86,369 | $-79,302 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 178,230 | 12,320 | 6,614 | N/A | N/A |
| Debt Repayment | -1,789 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 860,160 | 420,393 | 427,197 | N/A | N/A |
| Other Financing Activity | -14,557 | -3,428 | -2,537 | 0 | 0 |
| Financing Cash Flow | $1,022,044 | $429,285 | $431,274 | $N/A | $N/A |
| Exchange Rate Effect | -51,795 | 18 | -542 | N/A | N/A |
| Beginning Cash Position | 593,024 | 460,874 | 203,257 | N/A | N/A |
| End Cash Position | 1,382,422 | 581,447 | 485,976 | N/A | N/A |
| Net Cash Flow | $789,398 | $120,573 | $282,718 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,391 | -222,361 | -68,711 | N/A | N/A |
| Capital Expenditure | -75,430 | -43,223 | -36,136 | N/A | N/A |
| Free Cash Flow | -90,821 | -265,584 | -104,847 | 0 | 0 |